Cellular chemotaxis induced by wear particles from joint replacements.
The destruction of bone around joint replacements (periprosthetic osteolysis) is an adverse biological response associated with the generation of excessive wear particles. Wear debris from the materials used for joint replacements stimulate a chronic inflammatory and foreign body reaction that leads to increased osteoclast differentiation and maturation, and decreased bone formation. Wear debris induces both local and systemic trafficking of inflammatory cells to the site of particle generation. Recent studies have shown that this effect is mediated primarily by chemotactic cytokines (chemokines) including macrophage chemotactic protein-1 (MCP-1, also known as CCL2), macrophage inhibitory protein-1 (MIP-1), Interleukin-8 (IL-8 or CXCL8) and others. These ligands migrate along a concentration gradient to interact with G-protein-linked transmembrane receptors on the cell surface. Chemokines are involved in the innate and adaptive immune responses, angiogenesis, wound healing and tissue repair. In vitro, in vivo and tissue retrieval studies have shown that chemokine-directed systemic trafficking of polymorphonuclear leukocytes and cells of the monocyte/macrophage lineage to wear particles result in the release of pro-inflammatory factors and subsequent bone loss. Modulation of the chemokine ligand-receptor axis is a potential strategy to mitigate the adverse effects of wear particles from joint replacements.
Goodman
Stuart B
SB
Department of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA, United States. goodbone@stanford.edu
Ma
Ting
T
D002633:Chemotaxis / Q000276:immunology*; D016207:Cytokines / Q000276:immunology*; D006801:Humans; D007595:Joint Prosthesis / Q000009:adverse effects*; D007596:Joints / Q000276:immunology* / Q000473:pathology* / Q000601:surgery; D018448:Models, Immunological; D010014:Osteolysis / Q000209:etiology* / Q000276:immunology*
D016207:Cytokines
J Orthop Res. 2005 Mar;23(2):376-83
15734251
J Biomed Mater Res. 2000 Sep 5;51(3):360-8
10880077
J Am Acad Orthop Surg. 2008;16 Suppl 1:S49-55
18612014
Arthritis Res. 2000;2(3):165-8
11094423
J Bone Joint Surg Br. 1989 Aug;71(4):571-5
2768299
J Interferon Cytokine Res. 2009 Jun;29(6):313-26
19441883
J Bone Joint Surg Am. 1990 Feb;72(2):252-8
1968067
J Biomed Mater Res. 1977 Mar;11(2):157-64
140168
J Orthop Res. 2002 May;20(3):490-8
12038622
Acta Orthop. 2008 Feb;79(1):134-40
18283585
J Leukoc Biol. 1996 Jan;59(1):61-6
8558069
Clin Orthop Relat Res. 2004 Nov;(428):114-9
15534530
Biomaterials. 2010 Jan;31(1):77-82
19781765
J Biomed Mater Res B Appl Biomater. 2008 Feb;84(2):559-70
17618512
J Bone Miner Res. 2004 Dec;19(12):2065-77
15537451
Biomaterials. 2008 Dec;29(36):4760-5
18824259
J Biomed Mater Res. 2001 Jun 5;55(3):433-41
11255198
J Am Acad Orthop Surg. 2008;16 Suppl 1:S56-62
18612015
J Biomed Mater Res A. 2008 Jun 15;85(4):1043-51
17937417
J Am Acad Orthop Surg. 2008;16 Suppl 1:S72-5
18612019
Clin Orthop Relat Res. 1996 Dec;(333):4-14
8981878
J R Soc Interface. 2008 Nov 6;5(28):1263-78
18647740
J Arthroplasty. 2008 Aug;23(5):721-31
18534392
J Orthop Res. 1996 May;14(3):473-82
8676261
Dev Comp Immunol. 2004 May 3;28(5):443-60
15062643
Clin Orthop Relat Res. 1992 Jan;(274):60-78
1729024
J Am Acad Orthop Surg. 2008;16 Suppl 1:S42-8
18612013
J Bone Joint Surg Br. 1999 Jan;81(1):155-62
10068024
Semin Immunol. 2008 Apr;20(2):86-100
18162407
Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):281-6
16101534
J Orthop Res. 2004 Jan;22(1):21-9
14656655
FEBS Lett. 1989 Feb 27;244(2):487-93
2465924
J Bone Joint Surg Am. 2007 May;89(5):1081-9
17473147
J Am Acad Orthop Surg. 2008;16 Suppl 1:S1-6
18612002
J Bone Joint Surg Br. 1990 Nov;72(6):980-4
2246301
Med Device Technol. 2003 Oct;14(8):10-3
14603712
J Orthop Res. 2005 May;23(3):501-10
15885468
J Am Acad Orthop Surg. 2008;16 Suppl 1:S63-7
18612016
Cytokine. 2000 Jul;12(7):909-13
10880235
Biomaterials. 2007 Oct;28(29):4231-9
17631956
Biomaterials. 2007 Dec;28(34):5044-8
17645943
J Am Acad Orthop Surg. 2008;16 Suppl 1:S7-13
18612018
FEBS Lett. 1992 Jul 27;307(1):97-101
1639201
J Biomed Mater Res A. 2006 Apr;77(1):192-201
16392133
J Arthroplasty. 1993 Apr;8(2):179-88
8478634
J Orthop Res. 2001 Sep;19(5):970-6
11562149
J Biomed Mater Res A. 2008 Feb;84(2):464-74
17618502
Clin Cancer Res. 2008 Nov 1;14(21):6735-41
18980965
Biomaterials. 1984 Jan;5(1):5-10
6375747
Biomaterials. 2008 Jul;29(20):2941-53
18440630
Annu Rev Pharmacol Toxicol. 2002;42:469-99
11807180
Biomaterials. 2005 Jun;26(17):3549-55
15621245
J Biomed Mater Res A. 2005 Nov 1;75(2):288-94
16088891
J Orthop Res. 2005 Nov;23(6):1249-57
15950427
J Bone Joint Surg Br. 2003 Mar;85(2):288-91
12678371
Acta Orthop. 2005 Jun;76(3):412-20
16156472
Med Prog Technol. 1976 Jul 20;4(1-2):31-42
792673
Cytokine Growth Factor Rev. 2002 Dec;13(6):455-81
12401480
Front Biosci. 2008 Jan 01;13:2400-7
17981721